U.S. Markets closed

Why Exact Science Made the $2.8 Billion Deal for Genomic

Jul.30 -- Kevin Conroy, Exact Sciences Corp. chairman and chief executive officer, discusses the company's $2.8 billion purchase of Genomic Health. He speaks on "Bloomberg Markets: European Close."